BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Religare downgrades Cipla to sell
Continued R&D investments as well as front-end establishment costs in key markets would weigh on profitability over the medium-term without commensurate sales.